Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
WHO to endorse GLP-1 drugs for obesity, calls for global access The World Health Organization is poised to officially endorse GLP-1 medications like Wegovy and Zepbound for treating obesity in adults worldwide by August or September 2025
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
Ramanau A et al
Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth
Passeron T, Lim HW, Goh CL, Kang HY, Ly F, Morita A, et al
Och nu trappar polisen upp sitt arbete under sommaren, d det r en srskilt riskfylld tid fr barn och unga som lever under hedersfrtryck, sger sa Wallinder p NOA
US$ 20.86
US$ 25.30
US$ 23.37
US$ 27.35
US$ 27.35
